Login / Signup

Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.

Jun WangNa SunThomas KunzkeJian ShenAnnette FeuchtingerQian WangRaphael MeixnerRonan Le GleutIvonne HaffnerBirgit LuberFlorian LordickAxel K Walch
Published in: British journal of cancer (2024)
The patient cohort was conducted from a multicentre observational study (VARIANZ;NCT02305043).
Keyphrases
  • case report
  • single cell
  • neoadjuvant chemotherapy
  • epidermal growth factor receptor
  • clinical trial
  • study protocol
  • free survival
  • cross sectional
  • double blind
  • squamous cell carcinoma
  • tyrosine kinase
  • rectal cancer